Clin2
NCT06838520Possibly a fitNot yet recruiting

Hormone therapy and bone health in prostate cancer

Prostate Cancer (Adenocarcinoma)

Part of Cancer, Kidney & urinary clinical trials.

This study looks at how certain hormone treatments for prostate cancer might affect bone strength over time. It aims to help doctors understand how to protect bones in men with prostate cancer that has spread.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
18 years to 80 years
Study type
Observational

Who can take part

  • You are an adult man (18 or older)
  • You have been diagnosed with prostate cancer that has spread to other parts of the body
  • You have not had hormone therapy or bone-strengthening drugs before
  • You do not have osteoporosis or other bone diseases
  • You have not had cancer that spread to your spine
  • You are willing to participate for at least a year

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06306612Recruiting
Surgery plus hormone therapy for advanced prostate cancer

This trial tests whether removing the prostate (surgery) plus standard hormone therapy and chemotherapy can help men whose prostate cancer has spread to many places in the body. It is for men who have not yet had treatment for their cancer.

Shanghai, Shanghai Municipality
NCT06350825Recruiting· Phase 3
Surgery plus hormone therapy for advanced prostate cancer

This study tests if removing the prostate and giving strong hormone therapy works better than hormone therapy alone for men whose prostate cancer has spread. It aims to improve how long patients live without the cancer worsening.

Nanjing, Jiangsu
NCT05838716Recruiting· Phase 3
Vitamin D During Hormone Therapy for Prostate Cancer

This trial studies whether taking vitamin D while you are on prostate hormone therapy (ADT) affects your health outcomes. It may help by keeping vitamin D levels in a safe range during treatment.

Newark, Delaware
NCT07837063Not yet recruiting
Urine and blood markers for men with advanced prostate cancer on hormone therapy

This study looks at how well urine and blood tests can monitor treatment response in men with prostate cancer that has spread. It includes both men who are starting a new hormone therapy and those who have already been on one but are seeing their cancer progress.

Liverpool, Merseyside
NCT07134439Not yet recruiting
Muscle aging in older men starting hormone therapy

This study looks at how hormone therapy (ADT) affects muscle aging in older men with prostate cancer. It aims to understand why muscles weaken during this treatment, which could lead to better ways to protect muscle health in the future.

NCT06259279Recruiting
High impact training for prostate cancer with bone spread

This trial tests whether high impact exercise can help men with prostate cancer that has spread to their bones. You may qualify if you have bone metastases and are on hormone therapy.

Herlev, Herlev

Hear when a new Prostate Cancer (Adenocarcinoma) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.